Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy

Cancer immunotherapy has veered the paradigm of cancer treatment. Despite recent advances in immunotherapy for improved antitumor efficacy, the complicated tumor microenvironment (TME) is highly immunosuppressive, yielding both astounding and unsatisfactory clinical successes. In this regard, clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yuefei, Yu, Xiangrong, Thamphiwatana, Soracha D., Zheng, Ying, Pang, Zhiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714985/
https://www.ncbi.nlm.nih.gov/pubmed/33304779
http://dx.doi.org/10.1016/j.apsb.2020.08.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714985/
https://www.ncbi.nlm.nih.gov/pubmed/33304779
http://dx.doi.org/10.1016/j.apsb.2020.08.010

Ejemplares similares